| Filed On | Filing |
|---|---|
| 11 Sep 2024 |
8-K/A: Notice of Delisting or Failure to Satisfy a Listing Rule
On September 10, 2024, GRI Bio, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”), indicating that the Company no longer meets the mi... |
| 06 Jul 2023 |
8-K/A: Financial Statements and Exhibits
To the Board of Directors and Shareholders of GRI Bio, Inc.: |
| 26 May 2023 |
8-K/A: Financial Statements and Exhibits
Section 1.1 Registered Office. The registered office of the Corporation shall be fixed in the Certificate of Incorporation of the Corporation. |
Loading...
